JIGHX
Price
$32.68
Change
-$0.06 (-0.18%)
Updated
Jul 10 closing price
Net Assets
5.33B
REEBX
Price
$59.69
Change
+$0.06 (+0.10%)
Updated
Jul 10 closing price
Net Assets
134.67B
Interact to see
Advertisement

JIGHX vs REEBX

Header iconJIGHX vs REEBX Comparison
Open Charts JIGHX vs REEBXBanner chart's image
JHancock International Growth NAV
Price$32.68
Change-$0.06 (-0.18%)
VolumeN/A
Net Assets5.33B
American Funds EUPAC R2E
Price$59.69
Change+$0.06 (+0.10%)
VolumeN/A
Net Assets134.67B
JIGHX vs REEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JIGHX vs. REEBX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JIGHX is a Buy and REEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REEBX has more cash in the bank: 135B vs. JIGHX (5.33B). JIGHX pays higher dividends than REEBX: JIGHX (0.73) vs REEBX (0.42). JIGHX was incepted earlier than REEBX: JIGHX (10 years) vs REEBX (11 years). REEBX (1.27) is less costly to investors than JIGHX (0.90). JIGHX is a more actively managed with annual turnover of: 65.00 vs. REEBX (35.00). JIGHX has a lower initial minimum investment than REEBX: JIGHX (0) vs REEBX (250). JIGHX annual gain was more profitable for investors over the last year : 18.17 vs. REEBX (3.26). REEBX return over 5 years is better than : 12.11 vs. JIGHX (10.27).
JIGHXREEBXJIGHX / REEBX
Total Expense Ratio0.891.2770%
Annual Report Gross Expense Ratio0.901.2771%
Fund Existence10 years11 years-
Gain YTD20.76713.156158%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.33B135B4%
Annual Yield % from dividends0.730.42174%
Returns for 1 year18.173.26557%
Returns for 3 years35.0930.56115%
Returns for 5 years10.2712.1185%
Returns for 10 years59.4122.14268%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCRX1.840.14
+8.24%
TScan Therapeutics
APM0.930.03
+3.33%
Aptorum Group Limited
CEVA23.200.46
+2.02%
CEVA
VTRS9.250.02
+0.22%
Viatris
INTA46.95-0.19
-0.40%
Intapp